IBDEI03D ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1216,1,4,0)
 ;;=4^401.0
 ;;^UTILITY(U,$J,358.3,1216,1,5,0)
 ;;=5^Malignant Hypertension
 ;;^UTILITY(U,$J,358.3,1216,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,1217,0)
 ;;=401.9^^13^123^5.5
 ;;^UTILITY(U,$J,358.3,1217,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1217,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,1217,1,5,0)
 ;;=5^Hypertension, NOS
 ;;^UTILITY(U,$J,358.3,1217,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,1218,0)
 ;;=796.2^^13^123^5
 ;;^UTILITY(U,$J,358.3,1218,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1218,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,1218,1,5,0)
 ;;=5^Elev BP W/O Hypertension
 ;;^UTILITY(U,$J,358.3,1218,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,1219,0)
 ;;=402.00^^13^123^13
 ;;^UTILITY(U,$J,358.3,1219,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1219,1,4,0)
 ;;=4^402.00
 ;;^UTILITY(U,$J,358.3,1219,1,5,0)
 ;;=5^Malignant HTN HRT Disease
 ;;^UTILITY(U,$J,358.3,1219,2)
 ;;=^269594
 ;;^UTILITY(U,$J,358.3,1220,0)
 ;;=402.01^^13^123^14
 ;;^UTILITY(U,$J,358.3,1220,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1220,1,4,0)
 ;;=4^402.01
 ;;^UTILITY(U,$J,358.3,1220,1,5,0)
 ;;=5^Malignant HTN HRT W/CHF
 ;;^UTILITY(U,$J,358.3,1220,2)
 ;;=^269595
 ;;^UTILITY(U,$J,358.3,1221,0)
 ;;=402.10^^13^123^1.5
 ;;^UTILITY(U,$J,358.3,1221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1221,1,4,0)
 ;;=4^402.10
 ;;^UTILITY(U,$J,358.3,1221,1,5,0)
 ;;=5^Benign HTN HRT Disease
 ;;^UTILITY(U,$J,358.3,1221,2)
 ;;=^269598
 ;;^UTILITY(U,$J,358.3,1222,0)
 ;;=402.11^^13^123^1.7
 ;;^UTILITY(U,$J,358.3,1222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1222,1,4,0)
 ;;=4^402.11
 ;;^UTILITY(U,$J,358.3,1222,1,5,0)
 ;;=5^Benign HTN HRT W/CHF
 ;;^UTILITY(U,$J,358.3,1222,2)
 ;;=^269599
 ;;^UTILITY(U,$J,358.3,1223,0)
 ;;=402.90^^13^123^7
 ;;^UTILITY(U,$J,358.3,1223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1223,1,4,0)
 ;;=4^402.90
 ;;^UTILITY(U,$J,358.3,1223,1,5,0)
 ;;=5^HTN HRT Dis W/O CHF NOS
 ;;^UTILITY(U,$J,358.3,1223,2)
 ;;=^269601
 ;;^UTILITY(U,$J,358.3,1224,0)
 ;;=402.91^^13^123^6
 ;;^UTILITY(U,$J,358.3,1224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1224,1,4,0)
 ;;=4^402.91
 ;;^UTILITY(U,$J,358.3,1224,1,5,0)
 ;;=5^HTN HRT Dis W/CHF
 ;;^UTILITY(U,$J,358.3,1224,2)
 ;;=^269602
 ;;^UTILITY(U,$J,358.3,1225,0)
 ;;=403.00^^13^123^16
 ;;^UTILITY(U,$J,358.3,1225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1225,1,4,0)
 ;;=4^403.00
 ;;^UTILITY(U,$J,358.3,1225,1,5,0)
 ;;=5^Malignant HTN Ren W/O Renal Failure
 ;;^UTILITY(U,$J,358.3,1225,2)
 ;;=^269604
 ;;^UTILITY(U,$J,358.3,1226,0)
 ;;=403.01^^13^123^15
 ;;^UTILITY(U,$J,358.3,1226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1226,1,4,0)
 ;;=4^403.01
 ;;^UTILITY(U,$J,358.3,1226,1,5,0)
 ;;=5^Malignant HTN Ren W/Ren Failure
 ;;^UTILITY(U,$J,358.3,1226,2)
 ;;=^269605
 ;;^UTILITY(U,$J,358.3,1227,0)
 ;;=403.10^^13^123^3
 ;;^UTILITY(U,$J,358.3,1227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1227,1,4,0)
 ;;=4^403.10
 ;;^UTILITY(U,$J,358.3,1227,1,5,0)
 ;;=5^Benign HTN Ren W/O Renal Failure
 ;;^UTILITY(U,$J,358.3,1227,2)
 ;;=^269607
 ;;^UTILITY(U,$J,358.3,1228,0)
 ;;=403.11^^13^123^2
 ;;^UTILITY(U,$J,358.3,1228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1228,1,4,0)
 ;;=4^403.11
 ;;^UTILITY(U,$J,358.3,1228,1,5,0)
 ;;=5^Benign HTN Ren W/Renal Failure
 ;;^UTILITY(U,$J,358.3,1228,2)
 ;;=^269608
 ;;^UTILITY(U,$J,358.3,1229,0)
 ;;=403.90^^13^123^9
 ;;^UTILITY(U,$J,358.3,1229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1229,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,1229,1,5,0)
 ;;=5^HTN REN W/O Ren Fail
 ;;^UTILITY(U,$J,358.3,1229,2)
 ;;=^269609
 ;;^UTILITY(U,$J,358.3,1230,0)
 ;;=403.91^^13^123^8
